Sutro Biopharma (STRO) EBT Margin (QoQ) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sutro Biopharma | 242.87 Mn | 242.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -12,318.00 |
| Sep 30, 2025 | -56,851.00 |
| Jun 30, 2025 | 112,799.00 |
| Mar 31, 2025 | -219,278.00 |
| Dec 31, 2024 | 161,935.00 |
| Sep 30, 2024 | -30,290.00 |
| Jun 30, 2024 | 17,780.00 |
| Mar 31, 2024 | -48,873.00 |
| Dec 31, 2023 | 32,156.00 |
| Sep 30, 2023 | 8,820.00 |
| Jun 30, 2023 | 2,324.00 |
| Mar 31, 2023 | 898.00 |
| Dec 31, 2022 | -32,327.00 |
| Sep 30, 2022 | 619.00 |
| Jun 30, 2022 | 57,953.00 |
| Mar 31, 2022 | -30,537.00 |
| Dec 31, 2021 | 498.00 |
| Sep 30, 2021 | -34,089.00 |
| Jun 30, 2021 | 11,224.00 |
| Mar 31, 2021 | 20,269.00 |
| Dec 31, 2020 | -26,595.00 |
| Sep 30, 2020 | 12,961.00 |
| Jun 30, 2020 | 7,345.00 |
| Mar 31, 2020 | -14,316.00 |
| Dec 31, 2019 | -2,565.00 |
| Sep 30, 2019 | 2,588.00 |
| Jun 30, 2019 | 6,116.00 |
| Mar 31, 2019 | -18,439.00 |
| Dec 31, 2018 | 12,282.00 |
| Sep 30, 2018 | 7,169.00 |
| Jun 30, 2018 | 561.00 |
| Mar 31, 2018 | 17,483.00 |
| Dec 31, 2017 | -37,570.00 |